Cytokine-based therapies for Crohn's disease--new paradigms.
Cominelli
Fabio
F
Health Sciences Center, University of Virginia, Charlottesville, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology*; D016207:Cytokines / Q000037:antagonists & inhibitors* / Q000502:physiology; D006801:Humans; D000069285:Infliximab; D018664:Interleukin-12 / Q000276:immunology*; D012074:Remission Induction; D017211:Treatment Failure; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha; D018664:Interleukin-12; D000069285:Infliximab